Skip to main content
. Author manuscript; available in PMC: 2020 Oct 9.
Published in final edited form as: J Sex Med. 2019 May 9;16(6):872–879. doi: 10.1016/j.jsxm.2019.03.273

Table 3.

Probability of Remaining at Castrate Testosterone Level (<50 ng/dl) 24 Months after ADT Cessation

Percentage (CI 95%) Adjusted P value

Duration <6 months 3.1 (1.1–7.0) 0.011
≥6 months 12.4 (7.8–18.5)

Age <65 years 6.4 (3.1–11.7) 0.488
≥65 years 8.6 (5.0–13.5)

Baseline T <400 ng/dl 10.4 (6.6–15.4) 0.049
≥400 ng/dl 3.2 (0.9–8.0)

Diabetes Yes 9.1 (2.5–21.9) 0.833
No 7.4 (4.7–11.0)

Sleep Apnea Yes 0 (NA) 0.966
No 8.3 (5.5–11.9)

Overall 7.6 (5.3–10.9)